Literature DB >> 25473918

Antiangiogenic VEGF-A in peripheral artery disease.

Joshua M Boucher1, Victoria L Bautch2.   

Abstract

Vascular endothelial growth factor A (VEGF-A) is a potent proangiogenic cytokine elevated in patients with peripheral artery disease (PAD). A new study links impaired vascular regrowth in PAD to increased expression of an antiangiogenic splice variant of VEGF-A.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25473918     DOI： 10.1038/nm.3767

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


  15 in total

1.  Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training.

Authors:  W Schuyler Jones; Brian D Duscha; Jennifer L Robbins; Natasha N Duggan; Judith G Regensteiner; William E Kraus; William R Hiatt; Ayotunde O Dokun; Brian H Annex
Journal:  Vasc Med       Date:  2012-03-08       Impact factor: 3.239

Review 2.  Wnt5a: its signalling, functions and implication in diseases.

Authors:  A Kikuchi; H Yamamoto; A Sato; S Matsumoto
Journal:  Acta Physiol (Oxf)       Date:  2011-04-22       Impact factor: 6.311

3.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

4.  Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.

Authors:  Noriyuki Ouchi; Akiko Higuchi; Koji Ohashi; Yuichi Oshima; Noyan Gokce; Rei Shibata; Yuichi Akasaki; Akihiko Shimono; Kenneth Walsh
Journal:  Science       Date:  2010-06-17       Impact factor: 47.728

5.  The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.

Authors:  G Merdzhanova; S Gout; M Keramidas; V Edmond; J-L Coll; C Brambilla; E Brambilla; S Gazzeri; B Eymin
Journal:  Oncogene       Date:  2010-07-19       Impact factor: 9.867

Review 6.  Therapeutic angiogenesis for critical limb ischaemia.

Authors:  Brian H Annex
Journal:  Nat Rev Cardiol       Date:  2013-05-14       Impact factor: 32.419

7.  Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?

Authors:  Andrew J Makin; Natalia A Y Chung; Stanley H Silverman; Gregory Y H Lip
Journal:  Clin Sci (Lond)       Date:  2003-04       Impact factor: 6.124

8.  Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells.

Authors:  James A Stefater; Ian Lewkowich; Sujata Rao; Giovanni Mariggi; April C Carpenter; Adam R Burr; Jieqing Fan; Rieko Ajima; Jeffery D Molkentin; Bart O Williams; Marsha Wills-Karp; Jeffrey W Pollard; Terry Yamaguchi; Napoleone Ferrara; Holger Gerhardt; Richard A Lang
Journal:  Nature       Date:  2011-05-29       Impact factor: 49.962

9.  Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.

Authors:  Dawid G Nowak; Jeanette Woolard; Elianna Mohamed Amin; Olga Konopatskaya; Moin A Saleem; Amanda J Churchill; Michael R Ladomery; Steven J Harper; David O Bates
Journal:  J Cell Sci       Date:  2008-10-15       Impact factor: 5.285

Review 10.  Gene therapy and cell-based therapies for therapeutic angiogenesis in peripheral artery disease.

Authors:  Munehisa Shimamura; Hironori Nakagami; Hiroshi Koriyama; Ryuichi Morishita
Journal:  Biomed Res Int       Date:  2013-11-03       Impact factor: 3.411
View more
  3 in total

1.  Coordinated Activation of VEGF/VEGFR-2 and PPARδ Pathways by a Multi-Component Chinese Medicine DHI Accelerated Recovery from Peripheral Arterial Disease in Type 2 Diabetic Mice.

Authors:  Shuang He; Tiechan Zhao; Hao Guo; Yanzhi Meng; Gangjian Qin; David A Goukassian; Jihong Han; Xuimei Gao; Yan Zhu
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

2.  Computer Simulation of TSP1 Inhibition of VEGF-Akt-eNOS: An Angiogenesis Triple Threat.

Authors:  Hojjat Bazzazi; Yu Zhang; Mohammad Jafarnejad; Jeffrey S Isenberg; Brian H Annex; Aleksander S Popel
Journal:  Front Physiol       Date:  2018-05-30       Impact factor: 4.566

3.  VEGF-A splice variants bind VEGFRs with differential affinities.

Authors:  Spencer B Mamer; Ashley Wittenkeller; P I Imoukhuede
Journal:  Sci Rep       Date:  2020-09-02       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.